1/1

Export Ready

Ruxolitinib Rutinib Cream 1.5%

Name: Ruxolitinib Rutinib Cream 1.5%
SKU: 8495611
Price: 96.35 USD
Availability: InStock

Sold by BALAJI PHARMA · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 96.35 /Unit

In stock

Inclusive of all taxes

Minimum order: 1 Unit

Export Snapshot

MOQ

1 Unit

Lead time

On request

Packaging

Tube or jar (depending on manufacturer)

Shelf life / longevity

As per product specification

HSN Code

3004

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for BALAJI PHARMA.

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

BALAJI PHARMA

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ruxolitinib Rutinib Cream 1.5% is a prescription topical treatment for skin conditions like eczema and vitiligo. By inhibiting JAK enzymes, it reduces inflammation and aids in skin repigmentation. Proper application as directed by a healthcare provider is essential for effectiveness and safety. This cream is produced following rigorous quality standards to ensure patient well-being.

Product Description

Ruxolitinib Rutinib Cream 1.5% is a topical medication used to treat certain skin conditions such as atopic dermatitis (eczema) and vitiligo. Ruxolitinib, the active ingredient, is a Janus kinase (JAK) inhibitor that works by modulating the immune response, thereby reducing inflammation and skin depigmentation. The cream is applied directly to the affected areas as prescribed by a healthcare professional. Patients should follow the application guidelines to achieve optimal results and minimize potential side effects. Manufactured under strict quality controls, Ruxolitinib Rutinib Cream ensures safety and effectiveness for dermatological use.

Description provided by BALAJI PHARMA.

Specifications

Product Type	Topical dermatological cream
Active Pharmaceutical Ingredient (API)	Ruxolitinib
Concentration	1.5% w/w
Form	Cream
Indicated Skin Conditions	Eczema, Vitiligo
Application Route	Topical
Packaging	Tube or jar (depending on manufacturer)
Storage Conditions	Store in a cool, dry place away from direct sunlight
Shelf Life	As per manufacturing date (usually 24 months)
Regulatory Status	Prescription-only medication requiring healthcare supervision

Use cases

Category	Pharmaceuticals > Dermatology > Topical Dermatological Medications
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Tube or jar (depending on manufacturer)
Storage condition	As recommended by supplier
Origin	India
Form	Cream

Commercials (this seller)

Minimum order	1 Unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ruxolitinib Rutinib Cream 1.5%. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does Ruxolitinib Rutinib Cream 1.5% specifically help in treating vitiligo?

A: Ruxolitinib Rutinib Cream 1.5% works by inhibiting Janus kinase enzymes that contribute to inflammatory and autoimmune responses involved in the depigmentation process of vitiligo. This aids in promoting repigmentation of the affected skin areas.

Q: What precautions should be taken while using Ruxolitinib Rutinib Cream 1.5%?

A: Users should apply the cream only on affected areas as prescribed, avoid contact with eyes or mucous membranes, and monitor for any adverse reactions. Consulting a healthcare provider for appropriate usage duration is essential.

Q: Is Ruxolitinib Rutinib Cream 1.5% suitable for long-term use?

A: Long-term use should be under strict medical supervision as prolonged inhibition of JAK enzymes may affect immune functions. Treatment duration will be determined by the healthcare provider based on clinical response.

Q: Can Ruxolitinib Rutinib Cream 1.5% be combined with other topical treatments?

A: Concurrent use with other topical immunosuppressants or corticosteroids should only be done under medical advice to avoid increased side effects or interactions.

Q: What quality measures ensure the safety of Ruxolitinib Rutinib Cream 1.5%?

A: The cream is manufactured under stringent GMP and dermatological standards to ensure purity, potency, and safety, aligning with regulatory requirements for prescription dermatological drugs.

Question not answered? Ask sellers directly — typical response within 4 hours.